"Three and a half years ago, my wife was diagnosed with Stage 4 bladder cancer and given an estimated two years to live. At the time, the treatment that would ultimately save her life was still in clinical trials and not yet available to patients. When that therapy became approved in 2023, she was finally able to receive it and it has kept her alive, active, and relatively healthy ever since. That access gave us time we were never promised: time to live, to plan, and to be together. Clinical trials are not abstract research, they are lifelines. Without them, our story would look very different today."

“I founded this company for a simple reason…I looked around and said, ‘This technology should exist, and it doesn’t,’ and so I decided to found a company to create this technology.  And the interesting thing was the more I talked to my colleagues, the more I realized how much of a demand for this technology was out there.  We will fundamentally change the way clinical trials are offered to patients by combining elite software engineering with elite clinical knowledge, in a way that no one else in this space is able to.  We are extraordinarily unique in our ability to combine clinical knowledge and tech expertise to make something completely new.”